TCL Archive In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule November 5, 1976
TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013
TCL Archive Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says February 20, 1998